We have collected information about Rapidmist Delivery System for you. Follow the links to find out details on Rapidmist Delivery System.
https://link.springer.com/chapter/10.1007%2F978-1-4614-9524-6_19
Feb 04, 2014 · Oral-lyn™, an oral insulin spray formulation, has been developed by Generex Biotechnology. This delivery system is convenient for patients and can be self-administered using RapidMist™ technology. Insulin is sprayed via the RapidMist™ device into the mouth via an …Author: Meena Bansal, Sanjay Bansal, Rachna Kumria
https://www.researchgate.net/publication/278700982_The_RapidMist_System_for_Buccal_Delivery_of_Insulin
The RapidMist drug delivery system places human recombinant insulin in a liquid formulation so as to be delivered to the buccal mucosa with an asthma-like device.
https://generex.com/technology
RapidMist an advanced buccal drug delivery technology, is comprised of a proprietary formulation and a proprietary device design that is able to deliver drugs through the buccal mucosa safely, thereby eliminating the pain from and need for multiple injections.
https://www.researchgate.net/publication/247829003_Development_of_the_RapidMist_TM_drug_delivery_system_for_the_treatment_of_diabetes_cardiovascular_diseases_and_breakthrough_cancer_pain
Development of the RapidMist (TM) drug delivery system for the treatment of diabetes, cardiovascular diseases and breakthrough cancer pain Article in Drugs of the Future 30(3) · March 2005 with ...Author: P. Modi
https://www.polypeptide.com/wp-content/uploads/2019/10/1401702335538c47bf450c4.pdf
Part 2: Delivery Systems Although peptide manufacturers are not normally involved with the formulation or delivery of the drug product, they are certainly aware that many of their clients opt at the start of development for delivery by injection, usually with very simple liquid formulations (water, saline or a standard excipient). Most
https://www.prnewswire.com/news-releases/generex-announces-collaboration-with-nhtherapeutics-to-utilize-the-rapidmist-buccal-delivery-technology-for-leuprolide-300088429.html
Pursuant to a fee-for-service arrangement, Generex will develop a RapidMist™ formulation of Leuprolide designed to achieve the safe, simple, rapid, dose-specific, and effective administration of the active pharmaceutical ingredient into the human body via the buccal mucosa.
Searching for Rapidmist Delivery System?
You can just click the links above. The data is collected for you.
